ArticlePharmacological reports : PR2021

Correction to: The potential use of tideglusib as an adjuvant radio-therapeutic treatment for glioblastoma multiforme cancer stem-like cells.

Jolie Bou-Gharios et al.PubMed ↗Publisher ↗

No numbers read from the abstract.